antiplatelet drugs, low dose aspirin (30 mg/d)
DISEASE INTERVENTION COMPARISON RESULTS
N Engl J Med. 1991 Oct 31;325(18):1261-6 Randomized Controlled Trial
IN stroke, ischemic, transient ischemic attack, cerebral infarction, thrombotic The Use of
antiplatelet drugs, low dose aspirin (30 mg/d)
As Treatment, Chronic
Is equal Than
antiplatelet drugs, higher dose aspirin (300 mg/d)
To reduce, at 2.6 years, recurrent cardiovascular events (stroke myocardial infarction or vascular death): 14.7% with low dose VS 15.2% higher dose